跳至主要内容
临床试验/EUCTR2020-001076-14-FI
EUCTR2020-001076-14-FI进行中(未招募)1 期

Efficacy of Streptococcus salivarius K12 oral probiotic products in preventing acute otitis media: A randomized placebo-controlled trial.

Oulu University Hospital, Oulu, Finland0 个研究点目标入组 1,000 人开始时间: 2020年4月6日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age 1-6 years, attending City of Oulu day care or a sibling of a child attending day care. Written informed consent. No middle ear effusion at study entry.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 1000
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • No ongoing antimicrobial prophylaxis or immunosuppression/immunodeficiency.

研究者

发起方
Oulu University Hospital, Oulu, Finland

相似试验